CDKN1A and skin cancer: Studies have suggested that EGCG can also cause cell cycle arrest in A431 skin cancer cells by inhibiting Cip1/p21 with no other modifications in Kip1/p27, cyclin D1, and CDK2, but a decrease in CDK4 at low doses [27].